Back to search

Belgium· BE-AMP-SAM463244-00

Vokanamet 150 mg - 850 mg

A metformin and canagliflozin product containing metformin hydrochloride, registered in Belgium by Janssen-Cilag International. The same ATC class is registered in 11 of our 19 countries.

ATC A10BD16

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVokanamet 150 mg - 850 mgATCA10BD16REGISTER NO.BE-AMP-SAM463244-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Metformin and canagliflozin is registered in 11 of 19 countries.

Countries holding a registration under ATC A10BD16 (metformin and canagliflozin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Metformin and canagliflozin · ATC A10BD16

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Metformin Hydrochloride
Manufacturer
Janssen-Cilag International
Country
Belgium (BE)
ATC code
A10BD16
ATC class
Metformin and canagliflozin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

  • be_apb
    3215951
  • be_apb
    7713241
  • be_apb
    3150844

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for metformin and canagliflozin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Metformin and canagliflozin · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and canagliflozin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and canagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Diabetex, Glucophage
  • Bulgaria · Meglucon Xr, Metformin Interdos Pharma
  • Cyprus · Brotmin, Glucophage
  • Czechia · Brotmin, Glucomet
  • Germany · Glucophage, Juformin
  • Denmark · Forminet, Lyomet
  • Estonia · Brotmin, Diabufor Xr
  • Spain · Brotmin, Dianben
  • Finland · Forminet, Glucophage
  • France · Glimezit, Glucophage
  • United Kingdom (Northern Ireland) · Abiano, Axpinet
  • Greece · Glucoformin, Glucofree
  • Croatia · Aglurab, Belformin
  • Hungary · Adimet, Adimet Xr
  • Ireland · Glucophage, Metformin Accord
  • Iceland · Forminet, Glucophage
  • Italy · Glucophage, Glucophage Unidie
  • Lithuania · Brotmin, Metfogamma
  • Luxembourg · Glucophage, Metformax
  • Latvia · Brotmin, Glucient Sr
  • Malta · Brotmin, Glyformin
  • Netherlands · Glucient Sr, Glycofren
  • Norway · Forminet, Glucophage
  • Poland · Abmetfina Xr, Avamina
  • Portugal · Allmet, Glucophage
  • Romania · Brotmin, Glucophage
  • Sweden · Forminet, Glucophage
  • Slovenia · Aglurab, Glucophage
  • Slovakia · Glucophage, Glucophage Xr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd0220e3-8ab6-4497-aca6-9703fa79390d
GET /v1/drugs/dd0220e3-8ab6-4497-aca6-9703fa79390d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Vokanamet 150 mg - 850 mg",
  "name_fr": "Vokanamet 150 mg - 850 mg",
  "name_nl": "Vokanamet 150 mg - 850 mg",
  "amp_code": "SAM463244-00",
  "strengths": [
    "850.0000",
    "150.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Metformin Hydrochloride",
    "Canagliflozin Hemihydrate",
    "Canagliflozin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Metformin and Canagliflozin",
  "authorisation_numbers": [
    "EU/1/14/918/007",
    "EU/1/14/918/009",
    "EU/1/14/918/008"
  ]
}

See everything about metformin and canagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.